Europe's most valuable company has invested billions in Kalundborg on Denmark's coast - but it has many problems.

A newly published study in the New England Journal of Medicine highlighted this week that Novo Nordisk’s (NVO) GLP-1 agonist ...

OZEMPIC and other “weight loss” jabs have now been linked to ten deaths in the UK. There have also been 7,228 reports of illness associated with the drugs, citing nausea, vomiting and ...

Size means little in light of this company's prospects.

The Danish town of Kalundborg should be a boom town, as the main manufacturing site for the weight loss drug Wegovy. Can the ...

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed what Bloomberg called a "shocking first miss" during ...

The United States has developed new classes of drugs that could change civilisation, and Nigeria should not be left out. What ...

Novo Nordisk has acknowledged it will need antitrust ... by semaglutide-based medicines Ozempic and Wegovy. However, as the deal involves only three of 50 plans run by Catalent, and it has pledged ...

Coming up: Presidential election, Fed interest rate decision, earnings from Palantir, Novo Nordisk, Toyota Terry has 25 years experience in journalism and communications, reporting on a range of ...

Hedonia, an innovator in mobile mental health solutions, has unveiled new findings from its recent economic model ...

Egypt's former Minister of Tourism and Antiquities Zahi Hawass is on a mission, calling for the return of the priceless Queen Nefertiti bust currently exhibited at the Neues Museum in Berlin.

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...